Oral solid dosage forms containing amisulpride as the active pharmaceutical ingredient, available in multiple strengths for antipsychotic therapy. Pharmaceutical manufacturers supply them to wholesalers, distributors, psychiatric hospitals, and clinics where psychiatrists and pharmacists procure for schizophrenia management in inpatient and